• 1
    Foell D, Frosch M, Schulze zur Wiesch A, Vogl T, Sorg C, Roth J. Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop? Ann Rheum Dis 2004; 63: 2068.
  • 2
    Gottlieb BS, Keenan GF, Lu T, Ilowite NT. Discontinuation of methotrexate treatment in juvenile rheumatoid arthritis. Pediatrics 1997; 100: 9947.
  • 3
    Wallace CA, Huang B, Bandeira M, Ravelli A, Giannini EH. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum 2005; 52: 355462.
  • 4
    Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 3902.
  • 5
    Wallace CA, Ruperto N, Giannini E, for the Childhood Arthritis and Rheumatology Research Alliance (CARRA), the Pediatric Rheumatology International Trials Organization (PRINTO), and the Pediatric Rheumatology Collaborative Study Group (PRCSG). Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004; 31: 22904.
  • 6
    Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4: 24964.
  • 7
    Simon RM, Korn EL, McShane LM, Radmacher MD, Wright GW, Zhao Y. Design and analysis of DNA microarray investigations. New York: Springer-Verlag; 2003.
  • 8
    Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995; 57: 289300.
  • 9
    Ward JH. Hierarchical grouping to optimize an objective function. J Am Stat Assoc 1963; 58: 23644.
  • 10
    Allwein EL, Schapire RE, Singer Y, Kaelbling P. Reducing multiclass to binary: a unifying approach for margin classifiers. J Mach Learn Res 2001; 1: 11341.
  • 11
    Jarvis JN, Dozmorov I, Jiang K, Frank MB, Szodoray P, Alex P, et al. Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis. Arthritis Res Ther 2004; 6: R1532.
  • 12
    Kutukculer N, Caglayan S, Aydogdu F. Study of pro-inflammatory (TNF-α, IL-1α, IL-6) and T-cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: correlations with clinical and laboratory parameters. Clin Rheumatol 1998; 174: 28892.
  • 13
    Rae MT, Niven D, Ross A, Forster T, Lathe R, Critchley HO, et al. Steroid signalling in human ovarian surface epithelial cells: the response to interleukin-1α determined by microarray analysis. J Endocrinol 2004; 183: 1928.
  • 14
    Hotamisligil GS. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 2003; 27 Suppl 3: S535.
  • 15
    Dong C, Davis RJ, Flavell RA. MAP kinases in the immune response. Annu Rev Immunol 2002; 20: 5572.
  • 16
    Sigal LH. Basic science for the clinician 43: the mitogen-activated protein kinase family in inflammatory signaling. J Clin Rheumatol 2007; 13: 969.
  • 17
    Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004; 4: 61729.
  • 18
    Wahl SM, Chen W. Transforming growth factor-β-induced regulatory T cells referee inflammatory and autoimmune diseases. Arthritis Res Ther 2005; 7: 628.
  • 19
    Kriegel MA, Li MO, Sanjabi S, Wan YY, Flavell RA. Transforming growth factor-β: recent advances on its role in immune tolerance. Curr Rheumatol Rep 2006; 8: 13844.
  • 20
    De Jager W, Hoppenreijs EP, Wulffraat NM, Wedderburn LR, Kuis W, Prakken BJ. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study [published erratum appears in Ann Rheum Dis 2008;67:280]. Ann Rheum Dis 2007; 66: 58998.
  • 21
    Wedderburn LR, Robinson N, Patel A, Varsani H, Woo P. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum 2000; 43: 76574.
  • 22
    Nilsson BO. Modulation of the inflammatory response by estrogens with focus on the endothelium and its interactions with leukocytes. Inflamm Res 2007; 56: 26972.
  • 23
    Massaad C, Paradon M, Jacques C, Salvat C, Bereziat G, Berenbaum F, et al. Induction of secreted type IIA phospholipase A2 gene transcription by interleukin-1β: role of C/EBP factors. J Biol Chem 2000; 275: 2268694.
  • 24
    Miyazawa K, Mori A, Yamamoto K, Okudaira H. Transcriptional roles of CCAAT/enhancer binding protein-β, nuclear factor-κB, and C-promoter binding factor 1 in interleukin (IL)-1β-induced IL-6 synthesis by human rheumatoid fibroblast-like synoviocytes. J Biol Chem 1998; 273: 76207.
  • 25
    Nishioka K, Ohshima S, Umeshita-Sasai M, Yamaguchi N, Mima T, Nomura S, et al. Enhanced expression and DNA binding activity of two CCAAT/enhancer-binding protein isoforms, C/EBPβ and C/EBPδ, in rheumatoid synovium. Arthritis Rheum 2000; 43: 15916.
  • 26
    Galien R, Evans HF, Garcia T. Involvement of CCAAT/enhancer-binding protein and nuclear factor-κB binding sites in interleukin-6 promoter inhibition by estrogens. Mol Endocrinol 1996; 10: 71322.
  • 27
    Galien R, Garcia T. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-κB site. Nucleic Acids Res 1997; 25: 24249.
  • 28
    Jeong H, Tombor B, Oltval ZN, Barabasi AL. The large-scale organization of metabolic networks. Nature 2000; 407: 6514.
  • 29
    Jarvis JN, Petty HR, Tang Y, Frank MB, Tessier PA, Dozmorov I, et al. Evidence for chronic, peripheral activation of neutrophils in polyarticular juvenile rheumatoid arthritis. Arthritis Res Ther 2006; 8: R154.
  • 30
    Dong J, Horvath S. Understanding network concepts in modules. BMC Syst Biol 2007; 1: 24.
  • 31
    Albert R, Jeong H, Barabasi AL. Error and attack tolerance of complex networks. Nature 2000; 406: 37882.